This research targets rare genetic diseases caused by frameshift mutations using antisense oligonucleotides as “genetic band-aids.” By masking faulty DNA segments, it restores functional protein production. Demonstrated in muscular dystrophy models, this approach offers a scalable strategy to treat multiple rare diseases, addressing a major gap where most conditions lack effective therapies.

This research applies machine learning to genetic data to distinguish harmless DNA variations from cancer-causing mutations. By treating DNA like a crime scene, the model learns to identify which genetic changes truly drive breast cancer risk, supporting more accurate diagnosis and informed clinical decision-making.